Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (Ramp2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice

Molecular Endocrinology

Volumn 25, Issue 7, 2011, Pages 1244-1253

  Kadmiel, Mahita ^a   Fritz Six, Kimberly ^a   Pacharne, Suruchi ^b   Richards, Gareth O ^b   Li, Manyu ^a   Skerry, Tim M ^b   Caron, Kathleen M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; G PROTEIN COUPLED RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 2;

ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BREAST DEVELOPMENT; EMBRYO; ENDOCRINE DISEASE; FEMALE FERTILITY; GENDER; HAPLOINSUFFICIENCY; HYPERPROLACTINEMIA; HYPOPHYSIS; INTRAUTERINE GROWTH RETARDATION; KNOCKOUT MOUSE; LETHALITY; MAMMARY GLAND; MEDICAL RESEARCH; MOUSE; NONHUMAN; PHENOTYPE; POSTNATAL CARE; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETON MALFORMATION;

ANIMALS; ANIMALS, NEWBORN; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; FEMALE; FEMUR; FETAL DEATH; GENES, LETHAL; HAPLOINSUFFICIENCY; HYPERPLASIA; HYPERPROLACTINEMIA; INFERTILITY, FEMALE; LUMBAR VERTEBRAE; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PITUITARY GLAND; PREGNANCY; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; TIBIA;

MUS;

EID: 79959848145     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0400     Document Type: Article

References (32)

1. Sexton PM, Morfis M, Tilakaratne N, Hay DL, Udawela M, Christopoulos G, Christopoulos A 2006 Complexing receptor pharmacology: modulation of family BGprotein-coupled receptor function by RAMPs. Ann NY Acad Sci 1070:90-104
2. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM 1998 RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333-339
3. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM 2004 Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110
4. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK 2008 Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebocontrolled, parallel-treatment trial. Lancet 372:2115-2123
5. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM 2008 Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304-1312
6. Paone DV, Shaw AW, Nguyen DN, Burgey CS, Deng JZ, Kane SA, Koblan KS, Salvatore CA, Mosser SD, Johnston VK, Wong BK, Miller-Stein CM, Hershey JC, Graham SL, Vacca JP, Williams TM 2007 Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2, 3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4- (2- oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1- carboxamide (MK-0974). J Med Chem 50:5564-5567
7. Salvatore CA, Moore EL, Calamari A, Cook JJ, Michener MS, O'Malley S, Miller PJ, Sur C, Williams DL Jr, Zeng Z, Danziger A, Lynch JJ, Regan CP, Fay JF, Tang YS, Li CC, Pudvah NT, White RB, Bell IM, Gallicchio SN, Graham SL, Selnick HG, Vacca JP, Kane SA 2010 Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist. J Pharmacol Exp Ther 333:152-160
8. Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A, Kuwasako K, Tilakaratne N, SextonPM2003 Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278:3293-3297
9. Harikumar KG, Simms J, Christopoulos G, Sexton PM, Miller LJ 2009 Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor. Biochemistry 48:11773-11785
10. Bouschet T, Martin S, Henley JM 2005 Receptor-activity-modifying proteins are required for forward trafficking of the calciumsensing receptor to the plasma membrane. J Cell Sci 118:4709-4720
11. Kadmiel M, Fritz-Six K, Caron K 2010 Understanding RAMPs through genetically engineered mouse models. Austin, TX: Landes Bioscience
12. Fritz-Six KL, Dunworth WP, Li M, CaronKM2008 Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118:40-50
13. Dackor R, Fritz-Six K, Smithies O, Caron K 2007 Receptor activitymodifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 282:18094-18099
14. Li M, Yee D, Magnuson TR, Smithies O, CaronKM2006 Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. J Clin Invest 116:2653-2662
15. Grattan DR, Steyn FJ, Kokay IC, Anderson GM, Bunn SJ 2008 Pregnancy-induced adaptation in the neuroendocrine control of prolactin secretion. J Neuroendocrinol 20:497-507
16. Fisher RA 1972 Statistical methods, experimental design, and scientific inference. 14th ed. New York: Hafner Publishing
17. Caron KM, Smithies O 2001 Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc Natl Acad Sci USA 98:615-619
18. Dackor RT, Fritz-Six K, Dunworth WP, Gibbons CL, Smithies O, Caron KM 2006 Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 26:2511-2518
19. El-Hashash AH, Esbrit P, Kimber SJ 2005 PTHrP promotes murine secondary trophoblast giant cell differentiation through induction of endocycle, upregulation of giant-cell-promoting transcription factors and suppression of other trophoblast cell types. Differentiation 73:154-174
20. El-Hashash AH, Kimber SJ 2006 PTHrP induces changes in cell cytoskeleton and E-cadherin and regulates Eph/Ephrin kinases and RhoGTPases in murine secondary trophoblast cells. Dev Biol 290: 13-31
21. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM 1995 Overexpression of parathyroid hormonerelated protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 121:3539-3547
22. Wysolmerski JJ, Philbrick WM, Dunbar ME, Lanske B, Kronenberg H, Broadus AE 1998 Rescue of the parathyroid hormonerelated protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 125:1285-1294
23. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC 1994 Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126:1611-1623
24. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D 1996 Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175:166-176
25. Karaplis AC 2001 PTHrP: novel roles in skeletal biology. Curr Pharm Des 7:655-670
26. Lanske B, Amling M, Neff L, Guiducci J, Baron R, KronenbergHM 1999 Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 104:399-407
27. Guo J, Chung UI, Yang D, Karsenty G, Bringhurst FR, Kronenberg HM 2006 PTH/PTHrP receptor delays chondrocyte hypertrophy via both Runx2-dependent and -independent pathways. Dev Biol 292:116-128
28. Vuguin PM, Kedees MH, Cui L, Guz Y, Gelling RW, Nejathaim M, Charron MJ, Teitelman G 2006 Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 147:3995-4006
29. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G 2004 Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509-514
30. Cornish J, Callon KE, Coy DH, Jiang NY, Xiao L, Cooper GJ, Reid IR 1997 Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am J Physiol 273:E1113-E1120
31. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2___CT method. Methods 25:402-408
32. Gomez C, David V, Peet NM, Vico L, Chenu C, Malaval L, Skerry TM 2007 Absence of mechanical loading in utero influences bone mass and architecture but not innervation in Myod-Myf5-deficient mice. J Anat 210:259-271